Fintel on MSN

Cantor Fitzgerald Maintains Vanda Pharmaceuticals (VNDA) Overweight Recommendation

Fintel reports that on October 30, 2025, Cantor Fitzgerald maintained coverage of Vanda Pharmaceuticals (NasdaqGM:VNDA) with ...
Fintel on MSN

Piper Sandler Maintains BridgeBio Pharma (BBIO) Overweight Recommendation

Fintel reports that on October 30, 2025, Piper Sandler maintained coverage of BridgeBio Pharma (NasdaqGS:BBIO) with a ...

Apogee Therapeutics: Plan To Take Standard-Of-Care Status From Dupixent Is Risky

Apogee Therapeutics, Inc. targets atopic dermatitis with APG777, aiming to outperform Dupixent. Learn more about APGE stock ...

Biotech ETFs Hovering Around a 52-Week: Here's Why

Biotech is back! Regulatory tailwinds, cheaper valuations, and Fed cut hopes are boosting ETFs like XBI and IBB. Is the ...

Biotech startup Helex raises $3.5 million in round led by pi Ventures

Bluehill Capital, SOSV, and other global investors participated in the round. The Hyderabad- and US-based biotech startup ...
PharmiWeb

Pila Pharma’s capital raise oversubscribed by 293 percent to fund obesity studies

Biotech company Pila Pharma has recently completed a strongly oversubscribed share issue on Nasdaq First North in Stockholm. The raised capital of nearly SEK 30 million will finance the first steps of ...